Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -29.92% is 12% below its 5-year average of -26.61%, around the middle of its 5-year range (-102.12%–49.05%).
214.69% below its 12-month average of -9.51%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 3.31%.
OPERATING MARGIN
-29.92%
OPERATING MARGIN AVG TTM
-9.51%
OPERATING MARGIN AVG 3Y
-0.71%
OPERATING MARGIN AVG 5Y
-26.61%
OPERATING MARGIN AVG 10Y
-64.77%
OPERATING MARGIN AVG 15Y
-73.24%
OPERATING MARGIN AVG 20Y
-91.21%
CURRENT VS TTM AVG
-214.69%
CURRENT VS 3Y AVG
-4087.68%
CURRENT VS 5Y AVG
-12.44%
CURRENT VS 10Y AVG
+53.81%
CURRENT VS 15Y AVG
+59.15%
CURRENT VS 20Y AVG
+67.20%
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 862 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Sarepta Therapeutics, Inc.
Market Cap
$1.83B
Operating Margin
-29.92%
TTM Avg
-9.51%
3Y Avg
-0.71%
5Y Avg
-26.61%
Market Cap
$1.83B
Operating Margin
2.61%
TTM Avg
3.43%
3Y Avg
5.52%
5Y Avg
6.07%
Market Cap
$1.84B
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
-41.96%
5Y Avg
-55.47%
Market Cap
$1.85B
Operating Margin
-3084.76%
TTM Avg
-3233.57%
3Y Avg
-1812.12%
5Y Avg
-1208.08%
Market Cap
$1.81B
Operating Margin
29.46%
TTM Avg
25.49%
3Y Avg
21.64%
5Y Avg
22.06%
Market Cap
$1.81B
Operating Margin
-141.35%
TTM Avg
-151.41%
3Y Avg
-107.18%
5Y Avg
-79.23%
Market Cap
$1.86B
Operating Margin
50.14%
TTM Avg
6.82%
3Y Avg
-32.12%
5Y Avg
-473.91%
Market Cap
$1.87B
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Sarepta Therapeutics, Inc. (SRPT) | $1.83B | -29.92% | -9.51% | -0.71% | -26.61% |
| Astrana Health, Inc. (ASTH)vs › | $1.83B | 2.61% | 3.43% | 5.52% | 6.07% |
| Palvella Therapeutics, Inc. (PVLA)vs › | $1.84B | 0.00% | 0.00% | -41.96% | -55.47% |
| Azenta, Inc. (AZTA)vs › | $1.81B | -3.49% | -3.57% | -5.95% | -5.03% |
| Immunome, Inc. (IMNM)vs › | $1.85B | -3084.76% | -3233.57% | -1812.12% | -1208.08% |
| LeMaitre Vascular, Inc. (LMAT)vs › | $1.81B | 29.46% | 25.49% | 21.64% | 22.06% |
| Xencor, Inc. (XNCR)vs › | $1.81B | -141.35% | -151.41% | -107.18% | -79.23% |
| Novavax, Inc. (NVAX)vs › | $1.86B | 50.14% | 6.82% | -32.12% | -473.91% |
| Trevi Therapeutics, Inc. (TRVI)vs › | $1.87B | 0.00% | 0.00% | 0.00% | 0.00% |
| Generate Biomedicines, Inc. (GENB)vs › | $1.77B | -737.04% | -849.82% | -849.82% | -849.82% |
Gross Margin
58.6%
Operating Margin
-29.9%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 3.31% |
| 2026-03-31 | 49.05% |
| 2025-12-31 | -92.92% |
| 2025-09-30 | -25.89% |
| 2025-06-30 | 18.91% |
| 2025-03-31 | -40.33% |
| 2024-12-31 | 24.56% |
| 2024-09-30 | 4.75% |
| 2024-06-30 | -0.19% |
| 2024-03-31 | 8.44% |
| 2023-12-31 | 6.21% |
| 2023-09-30 | -6.28% |
| 2023-06-30 | -51.11% |
| 2023-03-31 | -54.47% |
| 2022-12-31 | -41.34% |
| 2022-09-30 | -57.04% |
| 2022-06-30 | -90.43% |
| 2022-03-31 | -41.21% |
| 2021-12-31 | -52.52% |
| 2021-09-30 | -18.19% |
| 2021-06-30 | -102.12% |
| 2021-03-31 | -103.36% |
| 2020-12-31 | -117.62% |
| 2020-09-30 | -95.24% |
| 2020-06-30 | -100.72% |
| 2020-03-31 | -103.83% |
| 2019-12-31 | -229.96% |
| 2019-09-30 | -124.79% |
| 2019-06-30 | -290.88% |
| 2019-03-31 | -87.79% |
| 2018-12-31 | -165.09% |
| 2018-09-30 | -89.31% |
| 2018-06-30 | -140.66% |
| 2018-03-31 | -47.58% |
| 2017-12-31 | -40.41% |
| 2017-09-30 | -99.90% |
| 2017-06-30 | -180.91% |
| 2017-03-31 | -240.15% |
| 2016-12-31 | -1630.60% |
| 2016-09-30 | 0.00% |
| 2016-06-30 | 0.00% |
| 2016-03-31 | 0.00% |
| 2015-12-31 | -5143.81% |
| 2015-09-30 | 0.00% |
| 2015-06-30 | 0.00% |
| 2015-03-31 | 0.00% |
| 2014-12-31 | -165637.04% |
| 2014-09-30 | -3179.89% |
| 2014-06-30 | -1171.93% |
| 2014-03-31 | -412.63% |
| 2013-12-31 | -1250.91% |
| 2013-09-30 | -598.20% |
| 2013-06-30 | -579.02% |
| 2013-03-31 | -344.55% |
| 2012-12-31 | -141.32% |
| 2012-09-30 | -91.17% |
| 2012-06-30 | -49.59% |
| 2012-03-31 | -61.31% |
| 2011-12-31 | -66.25% |
| 2011-09-30 | -149.80% |
| 2011-06-30 | -87.40% |
| 2011-03-31 | -38.69% |
| 2010-12-31 | -11.21% |
| 2010-09-30 | -43.63% |
| 2010-06-30 | -191.82% |
| 2010-03-31 | -641.91% |
| 2009-12-31 | -76.91% |
| 2009-09-30 | -46.05% |
| 2009-06-30 | -171.99% |
| 2009-03-31 | -113.17% |
| 2008-12-31 | -52.81% |
| 2008-09-30 | -114.84% |
| 2008-06-30 | -97.90% |
| 2008-03-31 | -244.41% |
| 2007-12-31 | -109.29% |
| 2007-09-30 | -292.42% |
| 2007-06-30 | -375.95% |
| 2007-03-31 | -1881.47% |
| 2006-12-31 | -50072.66% |
| 2006-09-30 | -54880.24% |
| 2006-06-30 | -39977.81% |
| 2006-03-31 | -14431.05% |
| 2005-12-31 | -346.05% |
| 2005-09-30 | -58.43% |
| 2005-06-30 | -13094.51% |
| 2005-03-31 | -12270.41% |
| 2004-12-31 | -1728.67% |
| 2004-09-30 | -55980.31% |
| 2004-06-30 | -19937.76% |
| 2004-03-31 | -7795.54% |
| 2003-12-31 | -5295.57% |
| 2003-09-30 | -1129.36% |
| 2003-06-30 | -2188.26% |
| 2003-03-31 | -1349.77% |
| 2002-12-31 | -2453.73% |
| 2002-09-30 | -2313.23% |
